Skip to main content
Fig. 10 | BMC Infectious Diseases

Fig. 10

From: Comparing clinical outcomes of piperacillin-tazobactam administration and dosage strategies in critically ill adult patients: a systematic review and meta-analysis

Fig. 10

a Risk of bias summary of included RCT’s: displaying details about each risk of bias item for each trial. Green (+) indicates ‘low risk’, red (−) indicates ‘high risk’ and yellow (?) indicates ‘unclear risk’. b Risk of bias assessment displaying judgements about each risk of bias item presented as percentages across all RCT’s

Back to article page